Reassessing Selenium for the Management of Hashimoto's Thyroiditis: The Selini Shines Bright for Autoimmune Thyroiditis Patients
Thyroid® · 2024-03 · 34 (3) · 292-294
DOI: 10.1089/thy.2024.0078 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thyroid®, online erschienen am 18.02.2024. Verfasst von Leonidas H Duntas. Beteiligte Einrichtung: Unit of Endocrinology, Metabolism and Diabetes, Evgenideion Hospital, National and Kapodistrian University of Athens, Athens, Greece. Hauptthemen laut MEDLINE: Selenium, Thyroiditis, Autoimmune, Hashimoto Disease. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Unit of Endocrinology, Metabolism and Diabetes, Evgenideion Hospital, National and Kapodistrian University of Athens, Athens, Greece.
ORCID-Profile: Leonidas H Duntas
Zitieren
APA
Duntas, L. H. (2024). Reassessing Selenium for the Management of Hashimoto's Thyroiditis: The Selini Shines Bright for Autoimmune Thyroiditis Patients. Thyroid®, 34(3), 292-294. https://doi.org/10.1089/thy.2024.0078
Vancouver
Duntas LH. Reassessing Selenium for the Management of Hashimoto's Thyroiditis: The Selini Shines Bright for Autoimmune Thyroiditis Patients. Thyroid®. 2024;34(3):292-294. doi:10.1089/thy.2024.0078
BibTeX
@article{Duntas2024,
author = {Duntas, Leonidas H},
title = {Reassessing Selenium for the Management of Hashimoto's Thyroiditis: The Selini Shines Bright for Autoimmune Thyroiditis Patients},
journal = {Thyroid®},
year = {2024},
volume = {34},
number = {3},
pages = {292--294},
doi = {10.1089/thy.2024.0078}
}
EUVIMED